Key facts
- Bluedrop Medical’s last known valuation is $127.9M (Dec 2025).
- It has raised $30.3M; the latest was Later Stage VC ($11.7M) in Dec 2025.
- Notable investors include Enterprise Ireland, European Innovation Council, Elkstone, Atlantic Bridge Capital, Western Development Commission — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Bluedrop Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Bluedrop Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bluedrop Medical
Developer of a diabetic foot monitoring device designed to enable early detection of foot ulcers. The company's device conducts daily foot scans and transmits data to the cloud for algorithmic analysis, enabling healthcare providers to identify complications sooner, prevent amputations, and improve patient outcomes while reducing treatment costs.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2014
- Employees
- 23
- Website
- bluedropmedical.com/
- Ownership
- Privately Held (backing)
Bluedrop Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bluedrop Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bluedrop Medical in its N-PORT filings yet. We sweep new filings monthly.